Literature DB >> 32016006

Programmed cell death protein 1/programmed death ligand-1 checkpoint blockade meets patient-derived organoids.

Lejia Sun1, Huayu Yang1, Yilei Mao1.   

Abstract

Entities:  

Year:  2019        PMID： 32016006      PMCID： PMC6976394          DOI： 10.21037/atm.2019.11.76

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  17 in total

1.  One checkpoint may hide another: inhibiting the TGFβ signaling pathway enhances immune checkpoint blockade.

Authors:  Aditi Gupta; Sadna Budhu; Taha Merghoub
Journal:  Hepatobiliary Surg Nutr       Date:  2019-06       Impact factor: 7.293

2.  The new era of precision medicine in hepatocellular carcinoma: the urgent need for promising biomarkers.

Authors:  Haruhiko Takeda; Hiroki Nishikawa; Yukio Osaki
Journal:  Hepatobiliary Surg Nutr       Date:  2018-12       Impact factor: 7.293

Review 3.  Personalized Cancer Medicine: An Organoid Approach.

Authors:  Hamidreza Aboulkheyr Es; Leila Montazeri; Amir Reza Aref; Massoud Vosough; Hossein Baharvand
Journal:  Trends Biotechnol       Date:  2018-01-20       Impact factor: 19.536

Review 4.  Immune checkpoint blockade: a common denominator approach to cancer therapy.

Authors:  Suzanne L Topalian; Charles G Drake; Drew M Pardoll
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

5.  Patient-derived xenografts, a multi-faceted in vivo model enlightening research on rare liver cancer biology.

Authors:  Massimo Moro; Michela Casanova; Luca Roz
Journal:  Hepatobiliary Surg Nutr       Date:  2017-10       Impact factor: 7.293

6.  T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.

Authors:  Alexander C Huang; Michael A Postow; Robert J Orlowski; Rosemarie Mick; Bertram Bengsch; Sasikanth Manne; Wei Xu; Shannon Harmon; Josephine R Giles; Brandon Wenz; Matthew Adamow; Deborah Kuk; Katherine S Panageas; Cristina Carrera; Phillip Wong; Felix Quagliarello; Bradley Wubbenhorst; Kurt D'Andrea; Kristen E Pauken; Ramin S Herati; Ryan P Staupe; Jason M Schenkel; Suzanne McGettigan; Shawn Kothari; Sangeeth M George; Robert H Vonderheide; Ravi K Amaravadi; Giorgos C Karakousis; Lynn M Schuchter; Xiaowei Xu; Katherine L Nathanson; Jedd D Wolchok; Tara C Gangadhar; E John Wherry
Journal:  Nature       Date:  2017-04-10       Impact factor: 49.962

Review 7.  Modelling cancer in microfluidic human organs-on-chips.

Authors:  Alexandra Sontheimer-Phelps; Bryan A Hassell; Donald E Ingber
Journal:  Nat Rev Cancer       Date:  2019-02       Impact factor: 60.716

8.  Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade.

Authors:  Wassim Abida; Michael L Cheng; Joshua Armenia; Sumit Middha; Karen A Autio; Hebert Alberto Vargas; Dana Rathkopf; Michael J Morris; Daniel C Danila; Susan F Slovin; Emily Carbone; Ethan S Barnett; Melanie Hullings; Jaclyn F Hechtman; Ahmet Zehir; Jinru Shia; Philip Jonsson; Zsofia K Stadler; Preethi Srinivasan; Vincent P Laudone; Victor Reuter; Jedd D Wolchok; Nicholas D Socci; Barry S Taylor; Michael F Berger; Philip W Kantoff; Charles L Sawyers; Nikolaus Schultz; David B Solit; Anuradha Gopalan; Howard I Scher
Journal:  JAMA Oncol       Date:  2019-04-01       Impact factor: 31.777

Review 9.  Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy.

Authors:  Pengfei Zhao; Li Li; Xiaoyue Jiang; Qin Li
Journal:  J Hematol Oncol       Date:  2019-05-31       Impact factor: 17.388

10.  Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures.

Authors:  Niklas K Finnberg; Prashanth Gokare; Avital Lev; Sergei I Grivennikov; Alexander W MacFarlane; Kerry S Campbell; Ryan M Winters; Karen Kaputa; Jeffrey M Farma; Abbas El-Sayed Abbas; Luigi Grasso; Nicholas C Nicolaides; Wafik S El-Deiry
Journal:  Oncotarget       Date:  2017-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.